Filing Details
- Accession Number:
- 0001019056-13-000395
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-18 16:20:54
- Reporting Period:
- 2012-04-12
- Filing Date:
- 2013-03-18
- Accepted Time:
- 2013-03-18 16:20:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875622 | Biospecifics Technologies Corp | BSTC | Pharmaceutical Preparations (2834) | 113054851 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1348315 | Kenneth Jeffrey Vogel | One Meadow Drive Lawrence NY 11559 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-04-12 | 594 | $14.89 | 514,067 | No | 4 | P | Indirect | Footnote |
| Common Stock | Acquisiton | 2012-04-13 | 800 | $14.69 | 514,867 | No | 4 | P | Indirect | Footnote |
| Common Stock | Acquisiton | 2012-04-17 | 200 | $14.83 | 515,067 | No | 4 | P | Indirect | Footnote |
| Common Stock | Acquisiton | 2012-04-19 | 400 | $14.28 | 515,467 | No | 4 | P | Indirect | Footnote |
| Common Stock | Acquisiton | 2012-04-24 | 400 | $14.08 | 515,867 | No | 4 | P | Indirect | Footnote |
| Common Stock | Acquisiton | 2012-04-23 | 199 | $13.95 | 516,066 | No | 4 | P | Indirect | Footnote |
| Common Stock | Acquisiton | 2012-05-02 | 400 | $14.35 | 516,466 | No | 4 | P | Indirect | Footnote |
| Common Stock | Acquisiton | 2012-05-03 | 200 | $14.17 | 516,666 | No | 4 | P | Indirect | Footnote |
| Common Stock | Acquisiton | 2012-05-08 | 200 | $13.49 | 516,866 | No | 4 | P | Indirect | Footnote |
| Common Stock | Disposition | 2012-08-15 | 9,750 | $0.01 | 507,116 | No | 4 | S | Indirect | Footnote |
| Common Stock | Acquisiton | 2012-12-27 | 178,265 | $14.07 | 685,381 | No | 4 | P | Indirect | Footnote |
| Common Stock | Disposition | 2013-01-16 | 9,000 | $0.01 | 676,381 | No | 4 | S | Indirect | Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | Footnote |
| No | 4 | P | Indirect | Footnote |
| No | 4 | P | Indirect | Footnote |
| No | 4 | P | Indirect | Footnote |
| No | 4 | P | Indirect | Footnote |
| No | 4 | P | Indirect | Footnote |
| No | 4 | P | Indirect | Footnote |
| No | 4 | P | Indirect | Footnote |
| No | 4 | P | Indirect | Footnote |
| No | 4 | S | Indirect | Footnote |
| No | 4 | P | Indirect | Footnote |
| No | 4 | S | Indirect | Footnote |
Footnotes
- 221,554 common shares owned by Jeffrey K. Vogel and 276,562 common shares held by Bio Partners LP (Jeffrey Vogel is the sole shareholder and President of Bio management Inc., the sole general partner of Bio Partners LP)
- 18,750 common shares were transferred to a limited partner of Bio Partners LP.
- 178,265 common shares are owned by the Jeanette Vogel Family Trust for whom, Jeffrey K. Vogel is one of the Trustees.
Billionaire Hedge Funds
